Odyssey Health, Inc. (ODYY)
OTCMKTS
· Delayed Price · Currency is USD
0.0600
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EST
Odyssey Health Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
6.00M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ADM Tronics Unlimited | 3.41M |
| AI Maverick Intel | 92.26K |
| Ludwig Enterprises | 207.00 |
| Kelyniam Global | 2.67M |
| Biotricity | 15.45M |
| REMSleep Holdings | 16.72K |
| BioElectronics | 1.61M |
| CYduct Diagnostics | 344.78K |
Odyssey Health News
- 6 days ago - Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue Growth - PRNewsWire
- 5 months ago - Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million - GlobeNewsWire
- 6 months ago - Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace - GlobeNewsWire
- 8 months ago - Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device - GlobeNewsWire
- 2 years ago - Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity - Accesswire
- 2 years ago - Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc. - Accesswire
- 2 years ago - Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc. - Accesswire
- 2 years ago - Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion - Accesswire